Diseases · Entity Annotation Prototype (beta)

1articles mentioning diseases

1disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: CPI-refractory disease ×

CPI-refractory disease

This disease is selected. Its supporting articles are shown below.

CPI-refractory disease1

Articles mentioning CPI-refractory disease

1 articles · page 1 of 1

1307 ICT01, a γ9δ2 T-cell-activating mAb, in combination with pembrolizumab elicits deep and durable responses in second-line patients with primary refractory melanoma: Results from EVICTION study

jitc · abstract · 2025-11-07 · 1 matching annotations

79.1%

CPI-refractory melanoma CPI-refractory disease melanoma pembrolizumab ICT01 ICT01-pembrolizumab ICT01-mediated

…zumab generated clinically meaningful anti-tumor efficacy in 2L CPI-refractory melanoma patients, indicating the potential to overcome resistance to ch…

Browse diseases

CPI-refractory disease

Articles mentioning CPI-refractory disease

1307 ICT01, a γ9δ2 T-cell-activating mAb, in combination with pembrolizumab elicits deep and durable responses in second-line patients with primary refractory melanoma: Results from EVICTION study